Metastatic Breast Cancer | Oncology Today with Dr Neil Love: An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer

Featuring an interview with Prof Giuseppe Curigliano, including the following topics: Counseling patients with newly diagnosed metastatic breast cancer (mBC); role of patient-reported outcomes and advocacy (0:00) Individualized selection of up-front therapy for patients with HR-positive, HER2-negative mBC (6:02) Selection and sequencing of treatment for patients with HR-positive, HER2-negative disease who experience progression on CDK4/6 inhibition (9:40) Current and future role of HER2-targeted therapy for HER2-low and HER2-ultralow mBC (19:46) Selection and sequencing of therapy for patients with metastatic triple-negative breast cancer (29:53) Emerging innovative interventions for the treatment of mBC (37:17) CME information and select publications